NO764039L - - Google Patents
Info
- Publication number
- NO764039L NO764039L NO764039A NO764039A NO764039L NO 764039 L NO764039 L NO 764039L NO 764039 A NO764039 A NO 764039A NO 764039 A NO764039 A NO 764039A NO 764039 L NO764039 L NO 764039L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- hydrogen
- stands
- compounds
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1571675A CH605934A5 (en) | 1975-12-03 | 1975-12-03 | Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs. |
| CH1664575A CH605858A5 (en) | 1975-12-22 | 1975-12-22 | Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs. |
| CH927976 | 1976-07-20 | ||
| CH931276 | 1976-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO764039L true NO764039L (en:Method) | 1977-06-06 |
Family
ID=27429211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO764039A NO764039L (en:Method) | 1975-12-03 | 1976-11-25 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4086353A (en:Method) |
| JP (1) | JPS5268177A (en:Method) |
| AU (1) | AU510820B2 (en:Method) |
| BE (1) | BE848962A (en:Method) |
| CA (1) | CA1082714A (en:Method) |
| DE (1) | DE2653005A1 (en:Method) |
| DK (1) | DK528976A (en:Method) |
| ES (1) | ES453861A1 (en:Method) |
| FI (1) | FI763385A7 (en:Method) |
| FR (1) | FR2333504A1 (en:Method) |
| GB (1) | GB1564327A (en:Method) |
| IE (1) | IE44316B1 (en:Method) |
| IL (1) | IL51028A (en:Method) |
| NL (1) | NL7613317A (en:Method) |
| NO (1) | NO764039L (en:Method) |
| NZ (1) | NZ182779A (en:Method) |
| PH (1) | PH12642A (en:Method) |
| PT (1) | PT65918B (en:Method) |
| SE (1) | SE424553B (en:Method) |
| YU (1) | YU293876A (en:Method) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982000824A1 (en) * | 1980-09-05 | 1982-03-18 | Geissmann F | 1h and 2h indazol derivatives and medicaments containing them |
| CN1556702A (zh) * | 2001-09-26 | 2004-12-22 | 具有作为激酶抑制剂的活性的氨基吲唑衍生物、它们的制备方法和含有它们的药物组合物 | |
| SE0402763D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Nitro indazole derivatives |
| SE0402762D0 (sv) * | 2004-11-11 | 2004-11-11 | Astrazeneca Ab | Indazole sulphonamide derivatives |
| PT1971601E (pt) * | 2005-11-15 | 2010-01-26 | Array Biopharma Inc | Derivados de n4-fenil-quinazolina-4-amina e compostos relacionados como inibidores de tirosina quinases receptoras do tipo i erbb para o tratamento de doenças hiperproliferativas |
| WO2007075847A2 (en) * | 2005-12-20 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Glucokinase activators |
| PT2178870T (pt) * | 2007-08-17 | 2018-11-09 | Lg Chemical Ltd | Compostos de indazol e indol como um inibidor de necrose celular |
| EP2230238B1 (en) * | 2008-01-04 | 2013-12-11 | LG Life Sciences Ltd. | Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
| KR101404151B1 (ko) * | 2011-11-25 | 2014-06-05 | 가톨릭대학교 산학협력단 | 안과 질환의 예방 및 치료용 약학 조성물 |
| WO2016115282A1 (en) | 2015-01-13 | 2016-07-21 | Vanderbilt University | Benzoisoxazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| WO2016115272A1 (en) | 2015-01-13 | 2016-07-21 | Vanderbilt University | Benzothiazole and benzisothiazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US10526323B2 (en) | 2015-01-30 | 2020-01-07 | Vanderbilt University | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3759903A (en) * | 1971-07-28 | 1973-09-18 | Squibb & Sons Inc | Thiazolinyl and thiazinyl derivatives of indazoles |
-
1976
- 1976-11-22 DE DE19762653005 patent/DE2653005A1/de not_active Withdrawn
- 1976-11-24 FI FI763385A patent/FI763385A7/fi not_active Application Discontinuation
- 1976-11-24 DK DK528976A patent/DK528976A/da not_active Application Discontinuation
- 1976-11-25 SE SE7613195A patent/SE424553B/xx unknown
- 1976-11-25 NO NO764039A patent/NO764039L/no unknown
- 1976-11-26 US US05/745,303 patent/US4086353A/en not_active Expired - Lifetime
- 1976-11-30 NL NL7613317A patent/NL7613317A/xx not_active Application Discontinuation
- 1976-11-30 GB GB49834/76A patent/GB1564327A/en not_active Expired
- 1976-12-01 IE IE2637/76A patent/IE44316B1/en unknown
- 1976-12-01 ES ES453861A patent/ES453861A1/es not_active Expired
- 1976-12-01 NZ NZ182779A patent/NZ182779A/xx unknown
- 1976-12-01 JP JP51143543A patent/JPS5268177A/ja active Pending
- 1976-12-01 IL IL51028A patent/IL51028A/xx unknown
- 1976-12-01 BE BE172887A patent/BE848962A/xx unknown
- 1976-12-01 PH PH19181A patent/PH12642A/en unknown
- 1976-12-02 PT PT65918A patent/PT65918B/pt unknown
- 1976-12-02 YU YU02938/76A patent/YU293876A/xx unknown
- 1976-12-02 CA CA267,015A patent/CA1082714A/en not_active Expired
- 1976-12-02 FR FR7636296A patent/FR2333504A1/fr active Granted
- 1976-12-03 AU AU20252/76A patent/AU510820B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7613317A (nl) | 1977-06-07 |
| CA1082714A (en) | 1980-07-29 |
| IE44316L (en) | 1977-06-03 |
| FI763385A7 (en:Method) | 1977-06-04 |
| SE424553B (sv) | 1982-07-26 |
| US4086353A (en) | 1978-04-25 |
| IL51028A (en) | 1980-06-30 |
| DE2653005A1 (de) | 1977-06-08 |
| IL51028A0 (en) | 1977-02-28 |
| NZ182779A (en) | 1979-08-31 |
| FR2333504B1 (en:Method) | 1980-08-29 |
| BE848962A (fr) | 1977-06-01 |
| GB1564327A (en) | 1980-04-10 |
| YU293876A (en) | 1982-05-31 |
| JPS5268177A (en) | 1977-06-06 |
| FR2333504A1 (fr) | 1977-07-01 |
| AU2025276A (en) | 1978-06-08 |
| PH12642A (en) | 1979-07-11 |
| SE7613195L (sv) | 1977-06-04 |
| ES453861A1 (es) | 1978-03-01 |
| IE44316B1 (en) | 1981-10-21 |
| PT65918A (fr) | 1977-01-01 |
| DK528976A (da) | 1977-06-04 |
| PT65918B (fr) | 1978-07-05 |
| AU510820B2 (en) | 1980-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU493966A3 (ru) | Способ получени производных 4-/2имидазолин-2-иламино/-2,1,3-бензотиадиазола | |
| NO764039L (en:Method) | ||
| NO762661L (en:Method) | ||
| US4224445A (en) | Thienothiazine derivatives | |
| SU557758A3 (ru) | Способ получени 4-азабензимидазолов или их солей | |
| NO136360B (en:Method) | ||
| IE41457B1 (en) | Thienothiazine derivatives | |
| SU566524A3 (ru) | Способ получени производных пиридо(1,2-а)-пиримидина или их солей | |
| US4061647A (en) | Thiazolidine derivatives | |
| US3847934A (en) | 7-(imidazolinyl-(2)-amino)-indazoles | |
| Zinnes et al. | 1, 2-Benzothiazines. 6. 3-Carbamoyl-4-hydroxy-2H-1, 2-benzothiazine 1, 1-dioxides as antiinflammatory agents | |
| NO845169L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
| NO124430B (en:Method) | ||
| NO814468L (no) | Tiazolinderivater, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiske preparater paa basis av disse forbindelser | |
| NO811667L (no) | Fremgangsmaate ved fremstilling av substituerte pyrazinyl-1,2,4-oxadiazoler | |
| US4090020A (en) | Thienothiazine derivatives | |
| NO803160L (no) | Pyrimidin-derivater. | |
| US3244723A (en) | Certain 4-aminothiazole compounds and their preparation | |
| NO130329B (en:Method) | ||
| US2839529A (en) | Isothiazole compounds | |
| DK156059B (da) | Analogifremgangsmaade til fremstilling af guanidinderivater | |
| NO162156B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tiadiazinonderivater | |
| NO133892B (en:Method) | ||
| NO821725L (no) | Fremgangsmaate for fremstilling av heterocykliske amidoxim-derivater. | |
| US4118501A (en) | Thiazolidine derivatives |